Chronic Myeloid Leukemia
Showing 26 - 50 of 224
Special Drug Use-results Surveillance of Scemblix Tablets
Recruiting
- Chronic Myeloid Leukemia
- Asciminib
-
Toyohashi, Aichi, Japan
- +24 more
Aug 10, 2022
Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online
Recruiting
- Myeloproliferative Neoplasm
- +2 more
- Online Mindfulness Meditation
- Internet-Based Webinars
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 9, 2022
Effect of Pharmacogenetics on Imatinib Plasma Level and Response
Active, not recruiting
- Chronic Myeloid Leukemia
- PCR
- HPLC-UV
-
Assiut, EgyptSouth Egypt Cancer Institute
Aug 6, 2022
Study Conducted Among Patients With CML
Completed
- Chronic Myeloid Leukemia
- Tyrosine Kinase Inhibitors (TKIs)
-
East Hanover, New JerseyNovartis Investigative Site
Jul 25, 2022
Chronic Myeloid Leukemia Trial in Worldwide
Recruiting
- Chronic Myeloid Leukemia
-
Montréal, Quebec, Canada
- +25 more
Jul 25, 2022
Chronic Myeloid Leukemia Trial in Germany (Nilotinib)
Completed
- Chronic Myeloid Leukemia
-
Mannheim, Baden-Wuerttemberg, Germany
- +69 more
Mar 21, 2022
Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))
Recruiting
- Multiple Myeloma
- +13 more
- RITA (App)
-
Milano, ItalyASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
Jul 6, 2022
Treatment Free Remission (TFR) in CML Patients (CML-CP)Study
Not yet recruiting
- Chronic Myeloid Leukemia
- Treatment-free Remission
- TFR(Treatment-Free Remission)
- (no location specified)
Jun 27, 2022
Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,
Recruiting
- Philadelphia Chromosome
- +4 more
- Azacitidine
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jun 23, 2022
Among CP-CML Participants Initiating Dasatinib inReal Life
Completed
- Chronic Myeloid Leukemia
- Non-Interventional
-
Paris, FranceLocal Institution
Jun 17, 2022
Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Fludarabine + Total Marrow Irradiation
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022
Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in Nashville (Patient-reported outcome measure,
Recruiting
- Chronic Myeloid Leukemia
- +3 more
- Patient-reported outcome measure
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 1, 2022
Chronic Myeloid Leukemia Trial in France (biological samples)
Completed
- Chronic Myeloid Leukemia
- biological samples
-
Belfort, France
- +3 more
May 31, 2022
sCD62L and SPARC in Chronic Myeloid Leukemia Patients During
Completed
- Chronic Myeloid Leukemia
- ELISA kit
-
Tanta, EgyptTanta University
May 18, 2022
Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)
Recruiting
- Chronic Myeloid Leukemia
- Myelofibroses
-
Chicago, IllinoisThe University of Chicago
May 16, 2022
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)
Recruiting
- Myeloid Leukemia, Acute
- +3 more
- Bendamustine Hydrochloride
- Cyclophosphamid
-
Saint Petersburg, Russian FederationRM Gorbacheva Research Institute
Apr 4, 2022
Chronic Myeloid Leukemia Trial in New York (Nilotinib)
Completed
- Chronic Myeloid Leukemia
-
New York, New YorkWeill Cornell Medical College
Mar 24, 2022
International Chronic Myeloid Leukemia Pediatric Study
Recruiting
- Chronic Myeloid Leukemia
-
Buenos Aires, Argentina
- +20 more
Mar 22, 2022
Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)
Active, not recruiting
- Chronic Myeloid Leukemia
-
Los Angeles, California
- +61 more
Mar 17, 2022
Intravenous Busulfan And Fludarabine Myeloablative Conditioning
Completed
- Acute Myeloid Leukemia
- +3 more
- (no location specified)
Mar 16, 2022
Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase
Recruiting
- Acute Myeloid Leukemia
- +3 more
- EAGD T-cell infusion (Phase I)
- EAGD T-cell infusion (Expansion)
-
Westwood, KansasUniversity of Kansas Cancer Center
Mar 15, 2022